The crystal structure of Lactococcus lactis dihydroorotate dehydrogenase A complexed with the enzyme reaction product throws light on its enzymatic function

Protein Science

Volumn 7, Issue 6, 1998, Pages 1269-1279

  Rowland, Paul ^a   Björnberg, Olof ^b   Nielsen, Finn S ^b   Jensen, Kaj Frank ^b   Larsen, Sine ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Dihydroorotate dehydrogenase; Enzyme product complex; Flavoprotein; Pyrimidine nucleotide biosynthesis; X ray crystallography

Indexed keywords

AMINO ACID; ASPARAGINE; BACTERIAL ENZYME; DIHYDROOROTATE DEHYDROGENASE; GLYCINE; LEUCINE; LYSINE; METHIONINE; OROTIC ACID; SERINE;

ARTICLE; BINDING SITE; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME MECHANISM; ENZYME STRUCTURE; HYDROGEN BOND; LACTOCOCCUS LACTIS; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); LACTOCOCCUS LACTIS; STREPTOCOCCUS;

EID: 2642708353     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560070601     Document Type: Article

References (27)

1. Andersen PS, Jansen PJG, Hammer K. 1994. Two different dihydroorotate dehydrogenases in Lactococcus lactis. J Bacteriol 176:3975-3982.
2. Andersen PS, Martinussen J, Hammer K. 1996. Sequence analysis and identification of the pyrKDbF operon from Lactococcus lactis including a novel gene, pyrK, involved in pyrimidine biosynthesis. J Bacteriol 178:5005-5012.
3. Björnberg O, Rowland P, Larsen S, Jensen KF. 1997. The active site of dihydroorotate dehydrogenase A from Lactococcus lactis investigated by chemical modification and mutagenesis. Biochemistry 36:16197-16205.
4. Brünger AT. 1992. X-plor. Version 3.1. A system for X-ray crystallography and NMR. New Haven, CT: Yale University Press.
5. Collaborative Computational Project Number 4. 1994. The CCP4 suite: Programs for protein crystallography. Acta Crystallogr D 50:760-763.
6. Davis JP, Cain GA, Pitts WJ, Magolda RL, Copeland RA. 1996. The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase. Biochemistry 35:1270-1273.
7. DeFrees SA, Sawick DP, Cunningham B, Heinstein PF, Morré DJ, Cassady JM. 1988. Structure-activity relationships of pyrimidines as dihydroorotate dehydrogenase inhibitors. Biochem Pharmacol 37:3807-3816.
8. Esnouf RM. 1997. An extensively modified version of Molscript that includes greatly enhanced coloring capabilities. J Mol Graph 15:133-138.
9. Hambley TW, Phillips L, Poiner AC, Christopherson RI. 1993. A crystallographic and molecular mechanics study of inhibitors of dihydroorotase. Acta Crystallogr B 49:130-136.
10. Hines V, Johnston M. 1989. Mechanistic studies on the bovine liver mitochondrial dihydroorotate dehydrogenase using kinetic deuterium isotope effects. Biochemistry 28:1227-1234.
11. Karibian D. 1978. Dihydroorotate dehydrogenase (Escherichia coli). Methods Enzymol 51:58-63.
12. Katritzky AR, Nesbit MR, Kurtev BJ, Lyapova M, Pojarlieff IG. 1969. NMR spectra and conformation of dihydrouracils and related compounds. Tetrahedron 25:3807-3824.
13. Knecht W, Bergjohann U, Gonski S, Kirschbaum B, Löffler M. 1996. Functional expression of a fragment of human dihydroorotate dehydrogenase by means of the baculovirus expression vector system, and kinetic investigation of the purified recombinant enzyme. Eur J Biochem 240:292-301.
14. Larsen JN, Jensen KF. 1985. Nucleotide sequence of the pyrD gene of Escherichia coli and characterization of the flavoprotein dihydroorotate dehydrogenase. Eur J Biochem 151:59-65.
15. 2 are structurally homologous and evolutionarily related enzymes with distinctly different function and flavin mononucleotide binding. J Biol Chem 266:3198-3207.
16. Morris AL, MacArthur MW, Hutchinson EG, Thornton JM. 1992. Stereochemical quality of protein structure coordinates. Proteins 12:345-364.
17. Nicholls A, Bharadwaj R, Honig B. 1993. GRASP: Graphical representation and analysis of surface properties. Biophys J 64:166-170.
18. Nielsen FS, Andersen PS, Jensen KF. 1996a. The B form of dihydroorotate dehydrogenase from Lactococcus lactis consists of two different subunits, encoded by the pyrDb and pyrK genes, and contains FMN, FAD, and [FeS] redox centers. J Biol Chem 271:29359-29365.
19. Nielsen FS, Rowland P, Larsen S, Jensen KF. 1996b. Purification and characterization of dihydroorotate dehydrogenase A from Lactococcus lactis, crystallization, and preliminary X-ray diffraction studies of the enzyme. Protein Sci 5:852-856.
20. Otwinowski Z. 1993. Oscillation data reduction program. In: Sawyer L, Isaacs N, Bailey S, eds. Data collection and processing. Proceedings of the CCP4 study weekend. Warrington, UK: SERC Daresbury Laboratory. pp 56-62.
21. Podschun B, Jahnke K, Schnackerz KD, Cook PF. 1993. Acid base catalytic mechanism of the dihydropyrimidine dehydrogenase from pH studies. J Biol Chem 268:3407-3413.
22. Porter DJT, Chestnut WG, Taylor LCE, Merrill BM, Spector T. 1991. Inactivation of dihydropyrimidine dehydrogenase by 5-iodouracil. J Biol Chem 266:19988-19994.
23. Read RJ. 1986. Improved Fourier coefficients for maps using phases from partial structures with errors. Acta Crystallogr A 42:140-149.
24. Rowland P, Nielsen FS, Jensen KF, Larsen S. 1997. The crystal structure of the flavin containing enzyme dihydroorotate dehydrogenase A from Lactococcus lactis. Structure 5:239-252.
25. Solbakk J. 1971. The crystal structure of ammonium orotate monohydrate. Acta Chem Scand 25:3006-3018.
26. Williamson RA, Yea CM, Robson PA, Curnock AP, Gadher S, Hambleton AB, Woodward K, Bruneau J-M, Hambleton P, Moss D, Thomson TA, Spinella-Jaegle S, Morand P, Courtin O, Sautés C, Westwood R, Hercend T, Kuo EA, Ruuth E. 1995. Dihydroorotate dehydrogenase is a high affinity binding protein for A77 1726 and mediator of a range of biological effects of the immunomodulatory compound. J Biol Chem 270:22467-22472.
27. Yokota H, Fernandez-Salguero P, Furuya H, Lin K, McBride OW, Podschun B, Schnackerz KD, Gonzalez FJ. 1994. cDNA cloning and chromosome mapping of human dihydropyrimidine dehydrogenase, an enzyme associated with 5-fluorouracil toxicity and congenital thymine uraciluria. J Biol Chem 269:23192-23196.